Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -2.99M
March 31, 2026 -1.067M
December 31, 2025 -3.722M
September 30, 2025 -1.476M
June 30, 2025 -1.38M
March 31, 2025 -0.395M
December 31, 2024 -2.589M
September 30, 2024 -0.394M
June 30, 2024 -1.455M
March 31, 2024 -161.76M
December 31, 2023 -99.29M
September 30, 2023 -0.867M
June 30, 2023 -1.067M
March 31, 2023 -0.10M
December 31, 2022 -0.962M
September 30, 2022 -162.18M
Date Value
June 30, 2022 -1.131M
March 31, 2022 -14.72M
December 31, 2021 -0.531M
September 30, 2021 -0.063M
June 30, 2021 -1.188M
March 31, 2021 -207.82M
December 31, 2020 -128.91M
September 30, 2020 -0.034M
June 30, 2020 -0.309M
March 31, 2020 -168.89M
December 31, 2019 -94.25M
September 30, 2019 -0.088M
June 30, 2019 -0.168M
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. -10.49M
Insmed, Inc. -28.01M
Emergent BioSolutions, Inc. 8.00M
Exelixis, Inc. 307.53M
Vertex Pharmaceuticals, Inc. 421.80M